Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk

This study has been terminated.
(Withdrawn due to poor accrual)
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Gynecologic Oncology Group
ClinicalTrials.gov Identifier:
NCT00017134
First received: June 6, 2001
Last updated: June 7, 2013
Last verified: November 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)